These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 20066878)

  • 1. [Recent advances in the knowledge of coronary flow disturbances after percutaneous coronary intervention].
    Capodanno D; Tamburino C
    Recenti Prog Med; 2009 Nov; 100(11):489-92. PubMed ID: 20066878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Percutaneous coronary intervention and the no-reflow phenomenon.
    van Gaal WJ; Banning AP
    Expert Rev Cardiovasc Ther; 2007 Jul; 5(4):715-31. PubMed ID: 17605650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pathogenesis and treatment of no-reflow occurring during percutaneous coronary intervention.
    Movahed MR; Butman SM
    Cardiovasc Revasc Med; 2008; 9(1):56-61. PubMed ID: 18206640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Refractory no-reflow successfully treated with local infusion of high-dose adenosine and verapamil--a case report.
    Dillon WC; Hadian D; Ritchie ME
    Angiology; 2001 Feb; 52(2):137-41. PubMed ID: 11228087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of combination therapy of adenosine and nitroprusside with adenosine alone in the treatment of angiographic no-reflow phenomenon.
    Barcin C; Denktas AE; Lennon RJ; Hammes L; Higano ST; Holmes DR; Garratt KN; Lerman A
    Catheter Cardiovasc Interv; 2004 Apr; 61(4):484-91. PubMed ID: 15065143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of intracoronary nicardipine in the treatment of no-reflow during percutaneous coronary intervention.
    Huang RI; Patel P; Walinsky P; Fischman DL; Ogilby JD; Awar M; Frankil C; Savage MP
    Catheter Cardiovasc Interv; 2006 Nov; 68(5):671-6. PubMed ID: 17034064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. "No-reflow" phenomenon following percutaneous coronary intervention: an uncommon complication.
    Safi AM; Kwan TW
    Angiology; 2000 Mar; 51(3):247-52. PubMed ID: 10744013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The no-reflow phenomenon: its incidence and clinical characteristics in a series of cases].
    Vallejo E; Peña-Duque MA; Noroño O; Ban Hayashi E; Gaspar J; Villavicencio R; Martínez Ríos MA
    Arch Inst Cardiol Mex; 1998; 68(3):247-52. PubMed ID: 9810347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention and treatment of microvascular obstruction-related myocardial injury and coronary no-reflow following percutaneous coronary intervention: a systematic approach.
    Jaffe R; Dick A; Strauss BH
    JACC Cardiovasc Interv; 2010 Jul; 3(7):695-704. PubMed ID: 20650430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of the no-reflow phenomenon.
    Butler MJ; Chan W; Taylor AJ; Dart AM; Duffy SJ
    Pharmacol Ther; 2011 Oct; 132(1):72-85. PubMed ID: 21664376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined assessment of myocardial perfusion and late gadolinium enhancement in patients after percutaneous coronary intervention or bypass grafts: a multicenter study of an integrated cardiovascular magnetic resonance protocol.
    Bernhardt P; Spiess J; Levenson B; Pilz G; Höfling B; Hombach V; Strohm O
    JACC Cardiovasc Imaging; 2009 Nov; 2(11):1292-300. PubMed ID: 19909933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of combination therapy of adenosine and nitroprusside with adenosine[correction for adensosine] alone in the treatment of angiographic no-reflow phenomenon: does 1 plus 1 equal 11?
    Bailey SR
    Catheter Cardiovasc Interv; 2004 Apr; 61(4):492-3. PubMed ID: 15065144
    [No Abstract]   [Full Text] [Related]  

  • 13. Impact of ultrasound attenuation and plaque rupture as detected by intravascular ultrasound on the incidence of no-reflow phenomenon after percutaneous coronary intervention in ST-segment elevation myocardial infarction.
    Endo M; Hibi K; Shimizu T; Komura N; Kusama I; Otsuka F; Mitsuhashi T; Iwahashi N; Okuda J; Tsukahara K; Kosuge M; Ebina T; Umemura S; Kimura K
    JACC Cardiovasc Interv; 2010 May; 3(5):540-9. PubMed ID: 20488411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. No-reflow is an independent predictor of death and myocardial infarction after percutaneous coronary intervention.
    Resnic FS; Wainstein M; Lee MK; Behrendt D; Wainstein RV; Ohno-Machado L; Kirshenbaum JM; Rogers CD; Popma JJ; Piana R
    Am Heart J; 2003 Jan; 145(1):42-6. PubMed ID: 12514653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reperfusion injury in acute myocardial infarction: from bench to cath lab. Part II: Clinical issues and therapeutic options.
    Monassier JP
    Arch Cardiovasc Dis; 2008 Sep; 101(9):565-75. PubMed ID: 19041841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of 'no-reflow' complicating reperfusion therapy.
    Lee KW; Norell MS
    Acute Card Care; 2008; 10(1):5-14. PubMed ID: 18449813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized evaluation of intracoronary nitroprusside vs. adenosine after thrombus aspiration during primary percutaneous coronary intervention for the prevention of no-reflow in acute myocardial infarction: the REOPEN-AMI study protocol.
    Niccoli G; D'amario D; Spaziani C; Cosentino N; Marino M; Rigattieri S; Schiavo PL; De Vita MR; Tarantino F; Bartorelli A; Fabbiocchi F; Prati F; Imola F; Valgimigli M; Ferrari R; Crea F
    J Cardiovasc Med (Hagerstown); 2009 Jul; 10(7):585-92. PubMed ID: 19384242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The no-reflow phenomenon in the coronary circulation.
    Kiernan TJ; Ruggiero NJ; Bernal JM; Don CW; Witzke C; Kiernan GD; Cubeddu RJ; Yan BP
    Cardiovasc Hematol Agents Med Chem; 2009 Jul; 7(3):181-92. PubMed ID: 19689256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracoronary boluses of adenosine and sodium nitroprusside in combination reverses slow/no-reflow during angioplasty: a clinical scenario of ischemic preconditioning.
    Parikh KH; Chag MC; Shah KJ; Shah UG; Baxi HA; Chandarana AH; Naik AM; Shah JN; Shah HD; Goyal RK
    Can J Physiol Pharmacol; 2007; 85(3-4):476-82. PubMed ID: 17612657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ultrasound attenuated coronary plaque as a risk factor for slow flow or no-reflow during percutaneous coronary intervention: a case report.
    Furuichi S; Itoh A; Ishibashi-Ueda H; Noguchi T; Miyawaki M; Nomura K; Arita Y; Otsuka M; Shindo T
    J Cardiol; 2007 Apr; 49(4):193-7. PubMed ID: 17460880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.